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Abstract
Background: Rats made hypothyroid with propilthyouracil start showing abnormal cycling on the second cycle
after the start of the treatment, with a high proportion of spontaneous pseudopregnancies and reduced fertility.
Methods: To investigate some of the mechanisms involved in these reproductive abnormalities, hypothyroidism
was induced in virgin rats by propilthyouracil (0.1 g/L in the drinking water) and we determined circulating
hormones by radioimmunoassay and whole ovary expression of ovarian hormone receptors, growth factors and
steroidogenic enzymes using semi-quantitative RT-PCR.
The study was performed on days 6 to 9 of treatment, corresponding to diestrus I (at 20.00-22.00 h), diestrus II (at
20.00-22.00 h), proestrus and estrus (both at 8.00-10.00 h and 20.00-22.00 h) of the second estrous cycle after
beginning propilthyouracil treatment. Another group of rats was mated on day 8 and the treatment continued
through the entire pregnancy to evaluate reproductive performance.
Results: Hypothyroidism increased circulating prolactin and estradiol on estrus 5 to 7-fold and 1.2 to 1.4-fold
respectively. Growth hormone and insulin-like growth factor 1 diminished 60 and 20% respectively on proestrus
morning. Hypothyroidism doubled the ovarian mRNA contents of estrogen receptor-beta on proestrus and estrus
evenings, cyp19A1 aromatase mRNA on estrus evening and of growth hormone receptor on proestrus evening.
Hypothyroidism did not influence ovulation rate or the number of corpora lutea at term, but a diminished number
of implantation sites and pups per litter were observed (Hypothyroid: 11.7 +/- 0.8 vs. Control: 13.9 +/- 0.7).
Conclusions: Short term hypothyroidism alters normal hormone profile in the cycling rat increasing the expression
of estrogen receptor-beta and cyp19A1 aromatase on estrus, which in turn may stimulate estradiol and prolactin
secretion, favouring corpus luteum survival and the subsequent instauration of pseudopregnancy.
Background
Hypothyroidism has a prevalence of 0.2 and 2% in male
and female populations respectively [1], and if left
untreated has severe consequences on the metabolism
and function of various organs and systems of the
organism, among them the reproductive system [2]. It
has been associated with menstrual abnormalities, ano-
vulation and hyperprolactinemia [3], which produce
ovulation disorders and reduced fertility in women of
childbearing age, with increased risk of miscarriage, pre-
mature delivery, placental abruption and poor perinatal
outcome with low birth weight [4-7]. Similar deleterious
effects of hypothyroidism on fertility are also observed
in many mammals [8,9]. The female reproductive cycle
depends on a complex interaction between the hypotha-
lamus, pituitary and ovary that interact through an
endocrine feedback system, regulating hormone secre-
tion and processes such as folliculogenesis, ovulation
and conception. Classically, the gonadotrophins, lutei-
nizing hormone (LH) and follicle stimulating hormone
(FSH) were considered as the main regulators of follicu-
lar proliferation and differentiation. However, more
recently a series of substances secreted by the ovary
have been found to participate in this regulation.
Among them are steroids like 17b-estradiol (E2)a n d
progesterone (P4), polypeptides such as inhibin, activin
and follistatin and growth factors including insulin-like
growth factor I (IGF I), epidermal growth factor, anti-
müllerian hormone, fibroblast growth factor and angio-
genic factors [10]. * Correspondence: gjahn@mendoza-conicet.gov.ar
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lation within the reproductive system. Triiodothyronine
(T3)a n dt h y r o x i n e( T 4)a r ep r e s e n ti nf o l l i c u l a rf l u i d
[11]. Granulosa cells of antral preovulatory follicles and
ovarian stromal cells express thyroid hormone receptors
a and b messenger RNA (mRNA) and protein. Thus, it
is conceivable that THs play an essential role in ovarian
physiology [12].
In adult rats, hypothyroidism apparently does not
directly produce sterility but during the first half of
gestation it increases embryonic reabsorption, resulting
in smaller litters and augmentation of fetal mortality,
although it does not seem to affect implantation [13-16].
On the other hand, hypothyroidism reduces fertility,
causing estrous cycle irregularities and spontaneous con-
secutive pseudopregnancies that are considered to be a
consequence of the hyper secretion of prolactin (PRL)
during proestrus (P) and estrus (E) [17,14].
The abnormal estrous cycles seen in hypothyroid
(HypoT) rats have been associated with diminished cir-
culating growth hormone (GH), IGFs and E2,a n d
administration of T4 to HypoT rats reverts the effect on
circulating hormones and normalizes the estrous cycle
[18]. However, the administration of GH to thyroidecto-
mized rats did not improve the timing of gestation, the
number of reabsorbed fetuses nor the number of pups
per litter [19]. Thus, the effect of hypothyroidism on
female sexual cycles may no be due solely to the altera-
tion of the GH/IGF axis.
Recently we have shown that virgin rats treated with
the antithyroid propilthyouracil (PTU) presented irregu-
lar cycles, spontaneous pseudopregnancies and altered
circulating ovarian hormones and PRL after the third
estrous cycle that resulted in mammary development
similar to that of midpregnancy. Furthermore, when the
rats were mated 8 days after the start of antithyroid
treatment they produced smaller litters [14].
To investigate the biochemical mechanisms involved
in the reproductive alterations (smaller litters and spon-
taneous pseudopregnacies) observed in HypoT rats, we
studied the early effects of PTU-induced hypothyroidism
on the female reproductive axis analyzing its effect on
basic reproductive parameters and ovarian function in
virgin rats on the second cycle after beginning antithyr-
oid treatment, that is the cycle when the rats were
mated on our previous study [14]. We evaluated the
early effect of hypothyroidism on the pattern of circulat-
ing hormones, the ovarian expression of several hor-
mone receptors, growth factors and steroidogenic
enzymes. We also measured the ovulation rate in virgin
rats and the number of corpora lutea, implantation sites
and pups at term to determine if the reduced litter size
of HypoT rats is associated with ovulation failure or
with postovulatory phenomena.
Methods
Animals
Adult female Wistar rats bred in our laboratory, 2-3
months old, weighing 200-230 g at the onset of treatment
and with regular 4 day cycles were used. Vaginal smears
from all animals were obtained daily to monitor the
estrous cycle. The rats were kept in a light (lights on 6.00
- 20.00 h) and temperature (22-24°C) controlled room.
Rat chow (Cargill, Cordoba, Argentina) and tap water or
PTU solution were available ad libitum. Animal mainte-
nance and handling was performed according to the NIH
g u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r yA n i m a l s( N I H
publication N8 86-23, revised 1985 and 1991) and the
UK requirements for ethics of animal experimentation
(Animals Scientific Procedures, Act 1986).
Experimental design
Hypothyroidism was induced by administration of PTU
at a concentration of 0.1 g/l in the drinking water. The
treatment was started on E day. To determine the pat-
tern of hormonal secretion and the function of the
ovary, groups of 8-10 HypoT or 8-10 control rats were
killed by decapitation during the second cycle after
initiation of the treatment, starting at diestrus (D) I and
at times selected so as to cover most of the stages of the
estrous cycle, such as the initiation (D I at 20.00-22.00
h) and end of the luteal phase (D II at 20.00-22.00 h),
the peak of estrogen surge on P morning (8.00-10.00 h),
the preovulatory peak on P evening (20.00-22.00 h) and
the postovulatory phase (E morning at 8.00-10.00 h and
evening at 20.00-22.00 h). The denominations of the
groups correspond to the time which the animals were
sacrificed. Trunk blood was collected and serum sepa-
rated by centrifugation and stored at -20°C until used
for subsequent determination of hormonal parameters.
The ovaries were rapidly removed, washed in a cold sal-
ine solution, snap-frozen in liquid nitrogen and stored
at -80°C until they were used for RNA preparation. To
determine the ovulation rate, the oviducts were also
removed from the rats sacrificed on E morning and the
ampullae were isolated. The oocytes were harvested by
applying gentle pressure to both ends of the ampulla,
placed on a slide in phosphate buffer saline and counted
under a stereomicroscope.
Another group of 8 rats were mated on the second P
(8 days) after starting the treatment. The presence of
spermatozoa in the vaginal smears the morning after
caging with a fertile male in P night was indicative of
mating and this day was counted as day 0 of pregnancy.
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individually. The day and hour of delivery and the num-
ber of pups were recorded. Another group of gestating
rats were killed by decapitation on day 21 of gestation
and the number of implantation sites of pups in utero
and of corpora lutea, in the ovaries, were recorded.
Hormone determinations
PRL, LH, FSH, GH and thyroid stimulating hormone
( T S H )w e r em e a s u r e db yd o u b l ea n t i b o d yr a d i o i m m u -
noassay using materials generously provided by Dr Par-
low and the NHPP (National Hormone and Pituitary
Program, Harbor-UCLA Medical Center, Torrance, CA,
USA) as previously described [14]. For each determina-
tion, all the samples were measured by duplicate in the
same assay, and the intra-assay coefficient of variance
was less than 10%
E2,P 4,T 3,T 4 and IGF 1 concentrations in sera were
measured in duplicate by radioimmunoassay using com-
mercial kits for total hormones DSL-4800, DSL-3400,
DSL-3100, DSL-3200 and DSL 2900 double antibody
radioimmunoassay, respectively; all from Diagnostic Sys-
tems Laboratories, Webster, TX). Inter- and intra-assay
coefficients of variation were less than 10%.
RNA isolation and semi-quantitative RT-PCR analysis
Total ovarian RNA was prepared using TRIZOL Reagent
(Invitrogen Life Technologies), following the manufac-
turer’s instructions for RNA isolation. Ten micrograms
of total RNA were reverse transcribed at 37°C using ran-
dom hexamer primers and Moloney murine leukemia
virus retrotranscriptase (Invitrogen/Life Technologies) in
a2 0μl reaction mixture. Aliquots of the reverse tran-
scription reaction mix complementary DNA (cDNA) cor-
responding to different quantities of cDNA for each
reaction were amplified with primers specific for the rat
and in the conditions described in Table 1. The condi-
tions and quantities of cDNA added were such that the
amplification of the products was in the exponential
phase and the assay was linear with respect to the
amount of input cDNA. The reactions were carried out
with the following cyclic parameters for cyp19A1 aroma-
tase and IGF receptor, type I (IGFIR): 95°C for 1 min, 56°
C1m i na n d7 2 ° C1m i n ;I G FB P - 5 :9 2 ° C1m i n . ,5 8 ° C1
min. and 72°C 1 min.; S16, long PRL receptor (PRLRlong),
GH receptor (GHR), estrogen receptor alpha (ERa), ERb:
95°C 1 min., 65°C 1 min. and 72°C 1 min.; IGF 1, IGF
BP-3: 95°C 1 min., 62°C 1 min. and 72°C 1 min. All the
reactions were terminated with a 5 min. extension at 72°
C. RNA samples were assayed for DNA contamination
by performing the different polymerase chain reactions
(PCR) without prior reverse transcription. The PCR pro-
ducts were analyzed on 1.5% agarose gels containing 0.5
mg/ml ethidium bromide and photographed using a
Kodak DC 290 Zoom Digital Camera. Band intensities of
semi-quantitative reverse transcription PCR (RT-PCR)
products were quantified using NIH Image software.
Relative levels of mRNA were expressed as the ratio of
signal intensity for the target genes relative to that for the
housekeeping gene rat ribosomal protein S16 cDNA.
Statistical analysis
Statistical analysis was performed using two-way analysis
of variance followed by the Bonferroni post hoc test to
compare any two individual means or using Student’st -
test when only two groups were compared [20]. When
variances were not homogeneous we performed log
transformation of the data. Differences between means
were considered significant at the P < 0.05 level.
Results
Effect of PTU treatment on serum concentrations of
thyroid, pituitary and ovarian hormones and IGF 1
PTU treatment was effective in inducing hypothyroid-
ism, as shown by the diminished levels of T3 and T4
and elevated levels of TSH (Figure 1).
Table 1 Primer sequences and reaction conditions used in the PCR amplification of the various cDNAs
Gene Sense primer (5’-3’) Anti-sense primer (5’-3’) Added
cDNA
(ng)
No.
of
cycles
Gene bank accession
N°
Product size
(pb)
Ref.
IGF I AAAATCAGCAGTCTTCCAAC AGATCACAGCTCCGGAAGCA 50 25 [GenBank:X06108] 299 [49]
S16 TCCAAGGGTCCGCTGCAGTC CGTTCACCTTGATGAGCCCATT 100 22 [GenBank:XM_341815] 100 [50]
IGFBP3 GCCGCGGGCTCTGCGTCAACGC CTGGGACTCAGCACATTGAGGAAC 200 25 [GenBank:NM_012588] 415 [49]
IGFBP5 TTGCCTCAACGAAAAGAGC AGAATCCTTTGCGGTCACA 100 25 [GenBank:NM_012817] 377 [49]
GHR GAGGAGGTGAACACCATCTTGGGC ACCACCTGCTGGTGTAATGTC 100 25 [GenBank:J04811] 534 [50]
ERa AATTCTGACAATCGACGCCAG GTGCTTCAACATTCTCCCTCCTC 200 25 [GenBank:X061098] 344 [50]
ERb AAAGCCAAGAGAAACGGTGGGCAT GCCAATCATGTGCACCAGTTCCT 100 25 [GenBank:U57439] 352 [50]
PRLLong AAAGTATCTTGTCCAGACTCGCTG AGCAGTTCTTCAGACTTGCCCTT 100 30 [GenBank:M74152] 279 [50]
IGFIR TCCACCATAGACTGGTCTCT ACGAAGCCATCTGAGTCACT 50 30 [GenBank:L29232] 433 [50]
P450arom TGCACAGGCTCGAGTATTTCC ATTTCCACAATGGGGCTGTCC 100 30 [GenBank:M33986] 271 [29]
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Page 3 of 11Figure 1 Circulating hormone concentrations during the estrous cycle in control and HypoT rats during the 2
nd estrous cycle after
initiation of PTU treatment (0.1 g/l in the drinking water). See Materials and Methods section for further details. The results represent the
means ± SEM of groups of 6-9 rats. * p < 0.05 compared with respective control group.
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secretion was observed in both groups and no differ-
ences between groups were detected during the estrous
cycle in LH or FSH (Figure 1), suggesting that PTU
treatment did not affect the pituitary secretion of these
hormones. On the other hand, although the preovula-
tory peak of PRL was normal in the HypoT rats, we
observed a significant increase in PRL concentrations
during E (Figure 1). Since GH secretion is also influ-
e n c e db yT H s ,w ea l s om e a s u r e dc i r c u l a t i n gG Hd u r i n g
the estrous cycle. Control rats showed a GH peak on P
morning. This peak was not observed in the HypoT rats
(Figure 1). Similarly, circulating IGF 1 in control rats
peaked on P and E mornings, and hypothyroidism
annulled these increases.
To evaluate the effect of hypothyroidism on the ovary
we also measured circulating E2 and P4 during the
estrous cycle in the rat. Hypothyroidism did not modify
serum P4 pattern (Figure 1). As expected both groups
showed increased levels during D I (luteal phase) and
during the preovulatory surge at P 20.00 h. E2 showed a
progressive increase from D I until P morning and then
diminished after ovulation. In HypoT rats the postovula-
tory decrease was less prominent, resulting in signifi-
cantly increased concentrations during E.
RT-PCR analysis of the relative expression of factors
related to the ovarian response to E2, PRL and
gonadotrophins during the estrous cycle
Since in the HypoT rats PRL and E2 levels were
increased during E (Figure 1), we evaluated the ovarian
response to these hormones determining the expression
of PRLRlong,E R a and ERb during the estrous cycle.
A surge in PRLRlong expression was observed (Figure 2)
o nP8 . 0 0h ,f o l l o w e db yas e c o n di n c r e a s eo nE2 0 . 0 0h .
The only effect of hypothyroidism was a diminished
expression on D I.
Expression of ERa showed a pattern similar to that
observed for PRLRlong, with two peaks on P morning and
E afternoon and a decrease on E 8.00 h. Hypothyroidism
did not modify this pattern significantly (Figure 2).
In control rats, ERb mRNA content (Figure 2) was
elevated on P 8 h, decreased progressively during P
afternoon and E and remained low on both D days. In
HypoT rats, the highest expression was observed on P
20.00 h, being significantly higher with respect to con-
trols, and a second increase with respect to the controls
was observed on E 20.00 h (Figure 2).
In order to determine the ovarian response to the cir-
culating FSH and LH and to explore the cause of the
increased circulating E2 observed in E (Figure 1), we
measured cyp19A1 aromatase expression on P and E. In
control rats the maximum expression was observed on
P 8.00 h, followed by low values on P evening and on E
(Figure 2). In HypoT rats the pattern was similar on P
and E morning, but on E 20.00 h cyp19A1 aromatase
expression was significantly higher compared to
controls.
RT-PCR analysis of GH/IGF 1 system relative expression in
the ovary during the estrous cycle
Based on the HypoT effects observed on circulating GH,
IGF 1 and E2 we evaluated the expression, relative to
S16, of several components of the GH/IGF axis during
the estrous cycle at ovarian level. IGF 1 content did not
vary during the estrous cycle and was not affected by
hypothyroidism (Figure 3). In contrast, there were signif-
icant differences in the expression of IGF binding pro-
teins (IGF BPs). IGF BP-3 content was highest on P 8.00
h (Figure 3), and showed the lowest values on both D
days. The same pattern was amplified in the HypoT rats
that had significantly higher values than controls on P
8.00 h and significantly lower values on D I and II (Fig-
ure 3).
IGF BP-5 showed a pattern similar to that of IGF BP-
3, with the highest values on P morning and lowest on
D days (Figure 3). The only effect of hypothyroidism on
IGF BP-5 content was a diminution on D I (Figure 3).
The expression of IGFIR in control rats (Figure 3) was
low on the D days, increased on P 8.00 h, diminished
the same day at 20.00 h, and then rose progressively
reaching maximum values on E 20.00 h. PTU treated
rats had a similar pattern, but showed diminished
expression on both D days.
In control rats GHR expression was stable during
most of the estrous cycle, except on D II, where there
was a marked decrease. HypoT rats had a similar pat-
tern, except for an increase in the expression on P 20.00
h (Figure 3).
Effect of PTU treatment on the ovulation rate in virgin
rats and the number of corpora lutea and implantation
sites at the end of gestation
We have previously shown that HypoT rats have smaller
litters [14]. To determine if this is a consequence of an
ovulatory deficit, the ovulation rate (measured as num-
ber of oocytes per rat in the oviduct on E morning) was
recorded in control and HypoT rats after 9 days of PTU
treatment. HypoT rats had a slightly lower ovulation
rate compared to controls, but the difference was not
statistically significant (Figure 4).
Next, we evaluated if the diminished number of pups
per litter was due to a defect in implantation or gesta-
tional development, by counting the implantation sites,
pups and corpora lutea in a group of HypoT and con-
trol rats at term. There were no differences in the num-
ber of corpora lutea but the number of implantation
sites and of pups per rat was significantly lower in
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mortality was observed in utero, however, the number
of implantation sites in HypoT rats was significantly
lower than the number of corpora lutea (Figure 4).
Discussion
Hypothyroidism is frequently associated with indirect
increases in circulating PRL that in turn increase the
risk of anovulation in women. Similarly, in the present
work we observed increased circulating PRL on the last
day of PTU treatment, corresponding to E, which may
be caused by the previously described increase in thyro-
tropin releasing hormone (TRH) provoked by the
HypoT state [21] and to the increased circulating E2
observed simultaneously. TRH has a potent stimulating
action on pituitary PRL secretion in the presence of ele-
vated levels of E2 [22] and E2 per se is a potent stimula-
tor of the synthesis and release of PRL. In the rat,
hyperprolactinemia reduces the pituitary response to
gonadotropin releasing hormone (GnRH), hindering
Figure 2 Ovarian mRNA content relative to S16 (see Materials and Methods section for further details) of PRLRlong,E R a,E R b and
cyp19A1 aromatase estimated by semi-quantitative RT-PCR in control and HypoT rats during the 2
nd estrous cycle after initiation of
PTU treatment. The results represent the means ± SEM of groups of 6-9 rats. * p < 0.05 compared with respective control group; § p < 0.05
compared with D 1 20.00 h; ‡ p < 0.05 compared with E 8.00 h.
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lamus more susceptible to stimuli capable of inducing
pseudopregnancies [24].
The effects of hypothyroidism on the gonadotrophic
axis are contradictory, some authors have found that
PTU treated rats had diminished concentration of LH
on D and P but the preovulatory surge was conserved
[25], while others describe a reduced proportion of ovu-
lating rats, but increased preovulatory levels of LH in
those rats that ovulated after radiochemical thyroidect-
omy with
131I [17]. We found no significant variations
on preovulatory LH levels on P, the eighth day after
initiation of PTU treatment. Most probably, the discre-
pancies between these three studies may be a conse-
quence of the different treatment paradigms used to
induce hypothyroidism. We did not find, either, any
effect on the ovulation rate, indicating that at this early
stage of PTU treatment, the gonadotrophic axis does
not seem to be affected.
On the other hand, the increased serum PRL observed
in E may be responsible for the induction of sponta-
neous pseudopregnancies that we observed after more
prolonged PTU treatments [14]. Other authors also have
found that hypothyroidism induces prolonged D accom-
panied with elevated circulating P4 indicative of pseudo-
pregnancy [17,25]. E2 regulates luteal function
facilitating the uptake of cholesterol for P4 synthesis
[26]. Thus, the elevated E2 a n dP R Lo b s e r v e di nEm a y
stimulate subsequent P4 synthesis and secretion in the
newly formed corpora lutea, which in turn triggers the
Figure 3 Ovarian mRNA content relative to S16 of IGF 1, IGF R, IGF BP-3, IGF BP-5 and GHR estimated by semi-quantitative RT-PCR in
control and HypoT rats during the 2
nd estrous cycle after initiation of PTU treatment. The results represent the means ± SEM of groups
of 6-9 rats.* p < 0.05 compared with respective control group; § p < 0.05 compared with D 1 20.00 h.
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luteal function and the pseudopregnant state [27].
The increased serum concentration of E2 observed
during E may be the result of a permissive action of
PRL that augments the number of luteal LH receptors.
This favours gonadotrophic action that in turn promotes
the conversion of P4 into androstenodione and then to
E2, a mechanism that has been described in the corpus
luteum of the rat [28]. Bao et al. [29] suggest that E2 sti-
mulates expression of cyp19A1 aromatase through bind-
ing to ERb in granulosa and luteal cells. Thus, we may
infer that the increased expression of cyp19A1 aroma-
tase on E is consequence of the elevated circulating E2
acting on elevated ERb that in turn stimulates E2 synth-
esis and PRL release. In this sense, a positive feedback
loop may be established leading to a sustained increase
in circulating PRL and E2 during E.
Rat ovaries express both short and long isoforms of
the PRLR, although the long one, PRLRlong,i st h em o s t
abundant and in agreement with our result, its expres-
sion surges on P [30]. Both isoforms are expressed in
the corpora lutea, granulosa and the interstitial cells
adjacent to the Graafian follicles, although in E and D I
the long isoform is majoritarily expressed on luteal tis-
sue [30]. ERs also are expressed in rat ovaries. ERa is
expressed in low levels in different types of ovarian cells
and in the oocyte, but it is not expressed in mature folli-
cles nor in the corpora lutea [31,32]. ERb is more highly
expressed in ovarian tissues, mostly in granulosa cells of
the developing follicles and to a lesser extent in the
newly formed corpora lutea [31,32]. It has also been
shown that PRL, acting through PRLRlong stimulates
ERa and ERb mRNA expression in the corpora lutea
and in primary culture of rat granulosa cells [33].
Although PRLRlong mRNA content was not modified by
hypothyroidism, the elevated circulating PRL concentra-
tions may be responsible for the high ERb mRNA con-
tent found on E.
On the other hand, since the increase in ERb mRNA
was observed on P, before the increase in PRL and E2,i t
may be a direct effect of hypothyroidism and have a role
in the subsequent increase in circulating E2 and PRL.
Thus, the increase in ERb may have increased the ovar-
ian response to circulating E2, which in turn stimulates
cyp19A1 aromatase expression and E2 synthesis. These
data suggest that the negative feedback exerted by E2
m a yb ep a r t i a l l yb l o c k e di nH ypoT rats, sensitizing the
ovary to E2 actions during P and E. Since it has been
largely demonstrated that, in the rat, E2 stimulates ster-
oidogenesis and luteal hypertrophy and synergizes with
Figure 4 Number of oocytes, corpora lutea and implantation sites in control and HypoT rats at the end of gestation.T h er e s u l t s
represent the means ± SEM of groups of 6-9 rats. * p < 0.05 compared with respective control group; § p < 0.05 compared with corpora lutea
counted in the HypoT group.
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mote corpus luteum survival favouring the establishment
of pseudopregnancy [26,34-37].
Since during E, cyp19A1 aromatase is almost exclu-
sively expressed in the corpus luteum [38], the increased
expression observed in the HypoT rats may be responsi-
ble for the increased levels of circulating E2 observed at
the same time.
Hypothyroidism also diminishes synthesis and secre-
tion of GH in the rat [39]. In particular, the stimulation
of GH release produced by E2depends on the participa-
tion of THs [40]. The GH surge observed on P morning
in the control rats may be due to the elevated circulat-
ing E2, and its absence in the HypoT rats may be
directly linked to the low levels of THs, that may have
offset the stimulatory action of E2. In addition, the low
GH levels on P may play a part in the decreased circu-
lating IGF 1 levels on P morning, since GH is the main
stimulus for hepatic IGF 1 production, and the liver is
the main source of this hormone [41]. The decreased
levels of IGF 1 on E morning, in contrast, may be a
direct effect of hypothyroidism.
Numerous investigations have demonstrated actions of
GH on steroidogenesis, gametogenesis and gonadal dif-
ferentiation. Many of these effects are mediated by local
actions of IGF 1. It has been postulated that this growth
factor has an essential participation in follicular develop-
ment [42] and ovarian steroidogenesis [10]. GH exerts
most of its effects in the ovary through binding to its
specific receptor. For example, mice lacking GHR pre-
sent a diminished ovulation rate, caused by the failure
of the ovarian response to gonadotrophins [43]. GH
promotes FSH-induced LH receptor (LHR) synthesis,
and the administration of IGF 1 does not improve the
ovulation rate, suggesting a direct participation of GH in
the ovulation process. IGF 1 promotes FSH receptor
(FSHR) expression, and in turn FSH augments both
IGFIR and FSHR. Besides, this growth factor exerts its
action through its own receptor, present in granulosa,
thecal and luteal cells. IGFIR expression is positively
r e g u l a t e db yF S H ,L Ha n dG H[ 1 0 ]a n di ti se x p r e s s e d
in the oocyte, mediating its maturation by IGF 1 [44].
Thus, the increase in GHR on P in the HypoT rats may
have compensated for the absent GH surge, allowing
follicle maturation to culminate in ovulation.
Bachelot et al. [43] reported that IGF 1 produced
locally in the ovary is independent of GH. Although our
present and previous results [14] showed that hypothyr-
oidism reduces serum levels of this growth factor
(mainly of hepatic origin) in virgin rats with prolonged
PTU treatment, we did not observe differences between
control and HypoT rats in ovarian IGF 1 mRNA, nor
between the days of the cycle. It is possible that IGF 1
regulation by THs is tissue specific, but we cannot
dismiss the possibility that this lack of effect is due to
the short length of the PTU treatment.
IGF BP-3 sequestrates circulating IGF 1, modulating
its action. IGF BP-3 is expressed preferentially in ovar-
ian theca and interstitial cells and it may have an antigo-
nadotrophic effect through sequestering of IGF 1. Our
results suggest an altered gonadotrophic response by the
diminished availability of IGF 1 on P, while on D I and
D II, in contrast, the lower IGF BP-3 concentrations
may allow IGF 1 to be more available. Fraser et al. [45]
demonstrated that IGF BP-3 expression in corpus
luteum is more intense during luteolysis. Thus, the
diminished expression observed during D may promote
corpus luteum survival, favouring the establishment of
pseudopregnancy.
IGF BP-5 is the most abundant IGF 1 binding protein
i nt h eo v a r y ,m a i n l ye x p r e s s e di nt h eg r a n u l o s ac e l l so f
atretic follicles, interstitial cells, corpus luteum and also
in the superficial epithelium [46,47]. Our results show
that IGF BP-5 expression was not affected on P, and
since in D IGF BP-5 is selectively expressed in superfi-
cial epithelium [46], we may assume that its activity is
not physiologically relevant at this moment.
Lastly, ovulation rate and the number of corpora lutea
were not affected significantly by the short term treat-
ment with PTU, suggesting that ovarian failure is not
responsible for the diminished number of pups per litter
previously observed [14]. However, the number of
implantation sites and of pups at delivery was smaller
than the number of corpora lutea in HypoT rats, sug-
gesting that the deleterious effects of hypothyroidism
are exerted on events that occur after ovulation. All
these data point to impairments in fertilization or
diminished capacity of the embryos to implant as a
probable cause of the reduced litters born to HypoT
mothers.
The factors affecting intrauterine fetal survival and/or
implantation that may be responsible for the diminished
number of pups per litter remain unclear and need
further investigation.
Hypothyroid women have increased rates of ovarian
failure and ovulatory dysfunctions [4,48]. The data pre-
sented in this investigation may contribute to the under-
standing of the influence of thyroid hormone disorders
on infertility and support the checking of thyroid status
in patients with reproductive alterations.
Conclusions
The present results show that during the second estrous
cycle after the start of PTU treatment the rats are
frankly HypoT and show some alterations in hormone
secretion, and in the expression of ovarian receptors,
members of the GH/IGF family and cyp19A1 aromatase
that may stimulate luteal function and survival and thus
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nancies previously observed [14,17,25]. On the other
hand, the observed effects of short-term hypothyroidism
do not seem to affect significantly the ovulation rate,
indicating that the smaller litters born to HypoT rats
seem to be caused by postovulatory events not linked to
ovulation rate or corpus luteum formation.
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